Exploration of Biomarkers of Psoriasis through Combined Multiomics Analysis

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Gene</td><td class="align_center">Drug</td><td class="align_center">Interaction types</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left"><i>GJB2</i></td><td class="align_center">OCTANOL</td><td class="align_center">Inhibitor (inhibitory)</td></tr><tr><td class="align_left"><i>GJB2</i></td><td class="align_center">CARBENOXOLONE</td><td class="align_center">Inhibitor (inhibitory)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Mediators of Inflammation

tab2

Table 2

Table 2: Exploration of Biomarkers of Psoriasis through Combined Multiomics Analysis 